1675 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1601 | 7926420 | [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy]. | 1993 Sep-Oct | 1 |
1602 | 8112499 | Metformin--an update. | 1993 Nov | 1 |
1603 | 8158383 | Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. | 1993 Dec | 1 |
1604 | 8222336 | Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin dependent diabetic patients and effects of metformin. | 1993 Sep | 1 |
1605 | 8339856 | Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects. | 1993 Mar-Apr | 1 |
1606 | 8387542 | Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. | 1993 May | 2 |
1607 | 8412779 | The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. | 1993 Sep | 2 |
1608 | 8453955 | Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. | 1993 | 6 |
1609 | 8462390 | Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. | 1993 Apr | 1 |
1610 | 8475636 | [Combination therapy of oral antidiabetic drugs with insulin]. | 1993 Mar | 1 |
1611 | 1505458 | Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. | 1992 Sep | 1 |
1612 | 1523352 | Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes. | 1992 Jan-Mar | 2 |
1613 | 1543016 | Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro. | 1992 Feb | 7 |
1614 | 1551495 | Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. | 1992 Mar | 5 |
1615 | 1569149 | Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. | 1992 May | 1 |
1616 | 1583082 | Metformin and blood pressure. | 1992 Apr | 3 |
1617 | 1600835 | Biguanides and NIDDM. | 1992 Jun | 2 |
1618 | 1752350 | Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. | 1991 Sep-Oct | 1 |
1619 | 1759920 | Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus. | 1991 Oct | 2 |
1620 | 1773025 | Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). | 1991 | 2 |
1621 | 1788832 | Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugs. | 1991 Nov 15 | 1 |
1622 | 1834486 | The insulin sparing effect of metformin in insulin-treated diabetic patients. | 1991 May | 3 |
1623 | 1900072 | Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. | 1991 Feb | 3 |
1624 | 1916049 | Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. | 1991 Jul | 2 |
1625 | 1936473 | Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. | 1991 May | 1 |
1626 | 1936475 | Management of type 2 diabetes mellitus with special reference to metformin therapy. | 1991 May | 3 |
1627 | 1936478 | Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. | 1991 May | 5 |
1628 | 1936479 | Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes. | 1991 May | 1 |
1629 | 1936485 | BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance. | 1991 May | 2 |
1630 | 1955512 | Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. | 1991 Dec | 1 |
1631 | 2086278 | Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients. | 1990 Dec | 3 |
1632 | 2191888 | Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. | 1990 Jul | 1 |
1633 | 2198745 | Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations. | 1990 Apr-Jun | 2 |
1634 | 2258095 | [Bedtime administration of metformin may reduce insulin requirements]. | 1990 Oct | 1 |
1635 | 2523787 | The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes. | 1989 Apr | 1 |
1636 | 2648723 | Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. | 1989 Mar | 2 |
1637 | 2702918 | Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics. | 1989 Jan 3 | 1 |
1638 | 3075902 | Treatment--metformin. | 1988 May | 2 |
1639 | 3149105 | Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy. | 1988 Jul-Sep | 1 |
1640 | 3239906 | [Lipoatrophic diabetes with insulin resistance controlled by metformin]. | 1988 | 1 |
1641 | 3115843 | Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. | 1987 Jul | 3 |
1642 | 3126223 | Effects of metformin and glibenclamide on insulin receptors in fibroblasts and tumor cells in vitro. | 1987 Dec | 5 |
1643 | 3310318 | Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. | 1987 Jun 3 | 1 |
1644 | 3329125 | [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. | 1987 Nov-Dec | 1 |
1645 | 3552509 | Role of metformin in treatment of diabetes mellitus. | 1987 Jan-Feb | 3 |
1646 | 3552515 | Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. | 1987 Jan-Feb | 5 |
1647 | 3552772 | Metformin enhances insulin binding to "in vitro" down regulated human fat cells. | 1987 Feb | 9 |
1648 | 3552795 | Mechanism of metformin action in non-insulin-dependent diabetes. | 1987 May | 1 |
1649 | 3533670 | Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients. | 1986 Aug | 3 |
1650 | 3745404 | Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. | 1986 Oct | 2 |